We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: More Effective Treatment for Early Alzheimer’s on the Horizon
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Health > More Effective Treatment for Early Alzheimer’s on the Horizon
HealthNews

More Effective Treatment for Early Alzheimer’s on the Horizon

Alzheimer's disease is becoming more common, but new research is making it easier to treat.

Aaron Casselman
Aaron Casselman
Share
4 Min Read
Close-up,Of,A,Person's,Hand,Holding,Ribbon,To,Support,Alzheimer's
Shutterstock Photo License - Andrey_Popov
SHARE

Over 5.8 million Americans suffer from Alzheimer’s disease. Sadly, the disease is becoming more common. The good news is that we are finally making strides in treating it.

Contents
  • A Look at the Challenges of Treating Early Alzheimer’s
  • New Early Alzheimer’s Medication Shows Promise of a Better Treatment

Alzheimer’s is a progressive disease of the brain that causes a slow decline in cognitive function. To date, no cure has been discovered for the condition, but treatments for the early stage of Alzheimer’s are showing promise in the form of slowing down its progression. 

Recently, promising medications have reached the market to help preserve the structures of the brain for longer, enabling individuals to retain more of their cognition, and live independently for as long as possible.

A lot of research has been done since science has recognized the existence of Alzheimer’s, but its causes have yet to be fully uncovered. The Alzheimer’s Association is publishing some case studies to help people better understand it. Amyloid plaques, long considered to be a sign of the disease, are now being viewed as part of the presentation as opposed to the cause. 

More Read

lactose intolerance
Everything You Need to Know About Lactose Intolerance
Demanding More From Medical Homes
Wikipedia: Study Confirms It Is a Reliable Source of Online Health Information
Online Meningitis Content Raises Concerns About Overall Prescription Drug Safety
Alzheimer’s and Exercise

Despite this limited understanding, great strides are still being made in the treatment of early Alzheimer’s, giving hope to sufferers and families alike. 

A Look at the Challenges of Treating Early Alzheimer’s

Treatment for Alzheimer’s consists mainly of managing the symptoms and behaviors that accompany the disease, more so than modifying its action. Currently there is only one medication that is approved for disease modification, known as aducanumab. The problem with aducanumab and related treatments are the adverse side effects. One of the major issues with the use of aducanumab is the fact that it targets the amyloid plaques in the brain and has an increased risk of swelling or bleeding in the brain. 

Other medications that are available for treatment have side effects that include gastrointestinal distress including nausea, diarrhea and vomiting, and can also cause headaches and dizziness. The side effects can be strong enough to cause the patient to stop their use, putting them at risk of faster onset of the middle and final stages of Alzheimer’s. 

New Early Alzheimer’s Medication Shows Promise of a Better Treatment

Many pharmaceutical companies are engaged in the treatment of Alzheimer’s and each are using different approaches to treat symptoms or limit its progression through various mechanisms. 

One medication that’s showing promise in the form of slowing down the disease is being produced by Anavex Life Sciences. The medication is currently known as Anavex2-73 (blarcamesine), and results from its recent Phase 2b/3 trial are promising. 

Anavex2-73’s action is one of restoring neural cell homeostasis and encouraging neuroplasticity in the brain. That is, the medication helps brain cells maintain their balance and function while resisting the effects of Alzheimer’s. So far, the medication has shown great promise when it comes to helping patients retain their cognitive function and slow their decline. The drug is also well-tolerated by study participants, which means more patients will be able to benefit from its use without the risk of adverse side effects. 

ANAVEX2-73 is different from other treatment options that currently exist for Alzheimer’s because science indicates that ANAVEX2-73 has a better side effect profile. For example, ANAVEX2-73 does not have any GI side effects. Additionally, ANAVEX2-73 has a longer duration of positive therapeutic impact than existing treatment options for Alzheimer’s disease.

Prof. Dr. Timo Grimmer

The lack of adverse side effects means that users are far more likely to stay on the medication while enjoying an improved quality of life. This can go a long way towards treating Alzheimer’s and detecting it earlier.

TAGGED:Alzheimer's Diseasedementia
Share This Article
Facebook Copy Link Print
Share
By Aaron Casselman
Aaron Casselman is a medical writer based in central Minnesota, specializing in bioinformatics. With my Master's Degree in bioinformatics, he brings unique insights into topics related to medicine and health.

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

No, This isn’t a Hotel

April 13, 2012
Gastritis disease reasons
HealthWellness

Gastritis: What to Eat, Diet, Best Medicines

December 26, 2022
celebrity health spokesperson
Medical EthicsNewsWellness

Celebrity Spokespeople: A Double-Edged Sword

June 25, 2013
botox
Health

How Long Does It Take For Botox to Wear Off?

April 12, 2022
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?